Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeynel A Sayiner

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|March 10, 2016
Lu-177 labelled peptide treatment for radioiodine refractory differentiated thyroid carcinomaUmut Elboğa, Mesut Özkaya, Zeynel A Sayiner, et al.
Gastroenterology & Hepatology|July 3, 2014
Hepatitis C virus infection and its rheumatologic implicationsZeynel A Sayiner, Uzma Haque, Mohammad U Malik, et al.
BMJ Case Reports|November 12, 2025
Treatment experience with secukinumab in two patients with ankylosing spondylitis and concomitant active tuberculosisFatih Albayrak, Nurcihan Y Savaş, Melis Mutlu, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|March 10, 2016
Lu-177 labelled peptide treatment for radioiodine refractory differentiated thyroid carcinomaUmut Elboğa, Mesut Özkaya, Zeynel A Sayiner, et al.
Gastroenterology & Hepatology|July 3, 2014
Hepatitis C virus infection and its rheumatologic implicationsZeynel A Sayiner, Uzma Haque, Mohammad U Malik, et al.
BMJ Case Reports|November 12, 2025
Treatment experience with secukinumab in two patients with ankylosing spondylitis and concomitant active tuberculosisFatih Albayrak, Nurcihan Y Savaş, Melis Mutlu, et al.
Pageof 1